Binding of the antagonist [3H ]candesartan to angiotensin II AT1 receptor-tranfected Chinese hamster ovary cells
- 19 February 1999
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 367 (2-3) , 413-422
- https://doi.org/10.1016/s0014-2999(98)00965-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Conformational Change Responsible for AT1 Receptor Activation Is Dependent upon Two Juxtaposed Asparagine Residues on Transmembrane Helices III and VIIPublished by Elsevier ,1997
- Two-point kinetic experiments to quantify allosteric effects on radioligand dissociationTrends in Pharmacological Sciences, 1996
- Pharmacological Properties of KT3–671, a Novel Nonpeptide Angiotensin II Receptor AntagonistJournal of Cardiovascular Pharmacology, 1995
- BMS‐180560, an insurmountable inhibitor of angiotensin II‐stimulated responses: comparison with losartan and EXP3174British Journal of Pharmacology, 1994
- Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic actionBritish Journal of Pharmacology, 1992
- Angiotensin II type-1 receptor subtype cDNAs: Differential tissue expression and hormonal regulationBiochemical and Biophysical Research Communications, 1992
- Identification of two subtypes in the rat type I angiotensin II receptorFEBS Letters, 1992
- Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research.Hypertension, 1991
- The serotonin‐S2 Receptor: A receptor‐transducer coupling model to explain insurmountable antagonist effectsDrug Development Research, 1986
- Desensitization, two-state receptors and pharmacological parametersJournal of Theoretical Biology, 1983